Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
42.78
+0.45 (1.06%)
Nov 22, 2024, 4:00 PM EST - Market closed
Qiagen Revenue
Qiagen had revenue of $501.87M in the quarter ending September 30, 2024, with 5.46% growth. This brings the company's revenue in the last twelve months to $1.97B, up 0.62% year-over-year. In the year 2023, Qiagen had annual revenue of $1.97B, down -8.23%.
Revenue (ttm)
$1.97B
Revenue Growth
+0.62%
P/S Ratio
4.84
Revenue / Employee
$329,508
Employees
5,967
Market Cap
9.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
| Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
| Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
| Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
| Dec 31, 2019 | 1.53B | 24.58M | 1.64% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Henry Schein | 12.50B |
| Encompass Health | 5.22B |
| Charles River Laboratories International | 4.06B |
| Exact Sciences | 2.69B |
| Bio-Rad Laboratories | 2.58B |
| Exelixis | 2.08B |
| Penumbra | 1.16B |
| Tempus AI | 640.44M |
QGEN News
- 15 days ago - Qiagen N.V. (QGEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Diagnostics firm Qiagen reports rise in third-quarter revenue - Reuters
- 19 days ago - QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics - GlobeNewsWire
- 25 days ago - QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment - GlobeNewsWire
- 6 weeks ago - QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications - GlobeNewsWire
- 6 weeks ago - QIAGEN N.V. to release results for Q3 2024 and hold webcast - GlobeNewsWire
- 6 weeks ago - Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer - GlobeNewsWire
- 7 weeks ago - QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology - GlobeNewsWire